Institutional investors purchased a net $7.3 million shares of CVM during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 10.13% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PARK WEST ASSET MANAGEMENT LLC Bought 7.5 Million shares of CEL-SCI Corp
THE VANGUARD GROUP, INC. Bought 106.7 Thousand shares of CEL-SCI Corp
BLACKROCK FUND ADVISORS Bought 65.1 Thousand shares of CEL-SCI Corp